Adjuvant Capecitabine In Triple Negative Breast Cancer: The Earlier, The Better? Comment


Guven D. C., Taban H., Dizdar O.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE, vol.28, no.1, pp.203-204, 2022 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Editorial Material
  • Volume: 28 Issue: 1
  • Publication Date: 2022
  • Doi Number: 10.1177/10781552211045909
  • Journal Name: JOURNAL OF ONCOLOGY PHARMACY PRACTICE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, International Pharmaceutical Abstracts, MEDLINE
  • Page Numbers: pp.203-204
  • Keywords: adjuvant, capecitabine, triple negative breast cancer, PHASE-III TRIAL, COMBINATION, DOCETAXEL
  • Hacettepe University Affiliated: Yes